SLAS International Conference and Exhibition attendees come to expect the latest in scientific discovery, technology and innovation – and SLAS2021 will be no different. Join your colleagues in San Diego, CA, (January 23 – 27) for the 10th anniversary of the first conference and exhibition.
SLAS2021 will once again feature 10 educational tracks to ignite discussions and brainstorming. Come early for the immersive and hands-on Short Courses on Saturday and Sunday, before settling into an abundance of scientific sessions and networking receptions and an Exhibition packed with more than 300 cutting-edge life sciences and technology that round out Monday through Wednesday’s programming.
And that’s not all. SLAS2021 will feature keynote speakers Deborah Sliptez, Ph.D., (Merck) and Atul Butte, M.D., Ph.D., (University of California Health System), both of whom will deliver impactful and relevant presentations on topics sure to get you excited about the future of drug discovery and automation technology.
Podium presentations at SLAS2021 are organized into ten educational tracks. Track and session titles and descriptions and names of track chairs and session chairs follow below.
The Scientific Program Committee selects speakers based on the innovation, relevance and applicability of research. If your proposed topic does not squarely fit into the focus of one of these tracks, please submit it for committee consideration regardless. The committee members use their judgment and experience to select presentations that best address the interests and priorities of today’s life sciences discovery and technology community.
Podium abstracts will be assessed in September and the podium program will be finalized and published by late-October.
The qualitative and quantitative characterization of endogenous and exogenous analytes in biological systems are the basis of drug discovery and development. This track will highlight important developments in bioanalytical technologies, including advances in label free technologies, applications of target and mechanism deconvolution techniques and ‘omics approaches to biomarker analysis. Planned sessions include:
Label Free Bioanalytical Techniques
Session Chair: Frank Buettner, Ph.D., Boehringer Ingelheim
Target Engagement and Pathways
Session Chair: Kilian Huber, Ph.D., University of Oxford
Target and Mechanism Deconvolution After Phenotypic Screens
Session Chair: Paul Tesar, Ph.D., Case Western Reserve University
This track will focus on recent innovations across the assay development and screening field, including the adoption of novel technologies and intelligent informatics approaches, to enable the implementation of effective screening campaigns and hit triage strategies to identify, validate and characterize potential leads. Attendees will hear about the development of robust, physiologically relevant biochemical, biophysical and cellular assays that are crucial for identifying active ligands that engage their targets directly. There will be an emphasis on recent case studies where cutting-edge assay approaches to improve the success rates of screening have been coupled with next-generation therapeutic modalities and novel mechanisms of action to broaden the scope of target classes that can be drugged. Planned sessions include:
Advanced Imaging and High-Content Assays
Session Chair: Regis Doyonnas, Ph.D., Pfizer
Applications of CRISPR Technology in Drug Discovery
Session Chair: Davide Gianni, Ph.D., AstraZeneca
Biochemical & Biophysical Assays
Session Chair: Larry Szewczuk, Ph.D., Janssen Pharmaceuticals
Session Chair: Patrick McEnaney, Ph.D., Haystack Sciences
In vitro Immunological Assays
Session Chair: Amy Quinn, Ph.D., GlaxoSmithKline
Session Chair: Christopher Parker, Ph.D., Scripps Research
This track focuses on the innovative use of biological or chemistry applications, tools, technologies, and techniques as they pertain to automated high throughput screening, the advancement of laboratory processes or improvement of the quality and impact of experimental laboratory data. Emphasis is placed on advancements in chemically and biologically relevant technologies using engineering, analytical, informatics, and application to cutting edge automation-assisted research. Planned sessions include:
Screening & Profiling at Higher-Throughput Using Physiologically Relevant Cell Models
Session Chair: Sylvia Boj, Ph.D., Hubrecht Organoid Technology
Technologies to Bridge the Gap Between High-Content and High-Throughput
Session Chair: James Pilling, M.S., AstraZeneca
Automating Screening Processes
Session Chair: Steven van Helden, Ph.D., Pivot Park Screening Centre
Automating Chemistry in the Age of AI
Session Chair: Lee Cronin, Ph.D., University of Glasgow
Microtiter Plates and Beyond: High-Throughput Miniaturization While Maintaining Physiological Relevance
Session Chair: Lorena Kallal, Ph.D., GlaxoSmithKline
In-house and Open Source Automation: Products, devices and software used to support laboratory automation
Session Chair: Pierre Baillargeon, M.S., Scripps Research
Attendees will learn from industry and academic leaders about new cellular technologies and their application in the understanding of normal physiology and disease, and in the generation of disease-relevant models for drug discovery and pre-clinical development. The track will cover models used for illuminating functional genomics and for pharmacology, ADME or toxicity outcomes. The technologies covered will include the generation and use of patient-derived models, iPSC models, complex co-cultures, organoids, organ-on-chips and microphysiologic models. The track will also include cellular therapeutics and cell technologies to support biologics and gene therapy approaches. Of particular interest will be the therapeutic areas of oncology, infectious diseases, immunology and rare diseases. Planned sessions include:
Novel and Innovative Applications of Cellular Technologies
Session Chair: Chris Hughes, Ph.D., Aracari Biosciences
Application of Disease-Relevant Cellular Models in Drug Discovery and Pre-Clinical Development
Session Chair: Marie-Claire Peakman, Ph.D., Pfizer
Development and Evaluation of Cellular Therapeutics
Session Chair: Sandra Santulli-Marotto, Ph.D., Bristol Myers Squibb
The world is rapidly transforming. Data are ambient and exist in volumes far exceeding the quantities imagined by the pioneers of our fields. As data volume and complexity continue to grow exponentially, so does the demand for tools which can rise to the occasion. Gone are the days of my data and your data. Analyzing single or even multiple sets of similar data will not yield the breakthroughs of the past but alongside the challenges are new opportunities for technology to empower discovery. This session will focus on the rapidly evolving role of digital technology and scientific information management as well as the hardware and software of the modern digital research lab. Emphasis will be placed on transforming data feeds from instruments into scientific understanding, particularly with the use of artificial intelligence and with additional consideration for distributed laboratories and the use of the cloud in the data ecosystem as we live through a global pandemic. Planned sessions include:
Lab of the Future
Session Chair: John Williams, Ph.D., Neurocrine
Building a Data Ecosystem
Session Chair: Marti Head, Ph.D., Oakridge National Lab
The Age of AI in the Lab
Session Chair: Joe Jacobson, Ph.D., MIT/DeepCure
Creating the next generation of small molecule drugs calls for novel drug target strategies. This track will provide assay and screening scientists with cutting edge information on technologies and methodologies that enable them to advance chemical matter for clinically relevant pharmacologies. Planned sessions include:
Drugging the Undruggable
Session Chair: Allison Olszewski, Ph.D., Civetta Therapeutics
Advances in Protein Homeostasis
Session Chair: Eunice Park, Ph.D., C4 Therapeutics
Targeting RNA Regulation
Session Chair: Tim Wigle, Ph.D., Ribon Therapeutics
Freeman Dyson famously said "when we make a new tool, we see a new cosmos". Micro and nano-scale tools have accelerated the pace of scientific discovery, particularly in next generation sequencing, single cell analysis, analytical chemistry, high throughput screening and point-of-care diagnostics. These tools leverage unique physics at small length scales, the ability to interact and interrogate biological systems at similar length scales and the ability to massively parallelize assays. Attendees will be given a broad overview of such emerging tools and their applications from both industry and academic leaders. This year's track will highlight advances in single cell analysis technologies, infectious disease theragnostics, and personalized medicine. Planned sessions include:
Microfluidic-Based Profiling of Eukaryotic and Microbial Cells at Single-Cell Resolution
Session Chair: Hee-Sun Han, Ph.D., University of Illinois
Disposable Near-Patient Testings for Infectious Disease
Session Chair: Nicolas Durand, Ph.D., Abionic
The emerging role of micro/nano innovations for personalized medicine
Session Chair: Soojung Hur, Ph.D., Johns Hopkins University
Planned sessions include:
Therapeutic Antibody Fragments
Session Chair: Andrew Bradbury, Ph.D., Specifica
Alternate Scaffolds with Clinical Potential
Session Chair: Yasmina Abdiche, Ph.D., Immunoprecise
Silencing Diseases at the Genetic Level Using siRNA
Session Chair: Karol Watson, M.D., Ph.D., UCLA Program in Preventive Cardiology
'Omics technologies have become an ineviatable part of drug research. While much attention has been put on (chemical)-proteomics have other 'omics-technologies yet received less awareness. In this track we will put the spotligth on metabolomics, transcriptomics and glycomics as upcoming techniques for drug research and biologics characterization. Planned sessions include:
Metabolomics in Drug Research
Session Chair: Baljit Uhbi, Ph.D., Sciex
Session Chair: Valeria Orlova, Ph.D., Leiden University Medical Center
Sweetening the Pot: Recent Advances in the Characterization of Biotherapeutic Glycoproteins
Session Chair: Guinevere Lageveen-Kammeijer, Leiden University Medical Center
The Precision Medicine for Drug Discovery track focuses on approaches that aim to resolve disease complexity. This includes molecular, biochemical, bioengineering and bioinformatic strategies in disease biology, diagnostics, screening and translational medicine. The session will emphasize the application of state-of-the-art, quantitative, high-throughput and high-resolution approaches to both cellular models and complex tissues. These strategies enable multiparametric computational analyses to reveal the complex interplay of genetics, cell types and drugs to advance precision medicine. Topics include improvements in stem cell-based disease modelling, bioengineering, molecular and cellular assay and bioinformatic approaches. Planned sessions include:
Closing the Gap Between Assay and Patient
Session Chair: Stephane Richard, Ph.D., Oncodesign
Applications of Single-Cell Analysis to Disease Studies
Session Chair: Nichol Miller, Ph.D., Pfizer
Session Chair: Kate Hastie, Ph.D., La Jolla Institute for Immunology
Stay tuned for sponsor and exhibit opportunities information. Coming soon!
Create a spark at SLAS. Submit your research for presentation and award consideration at the 2021 SLAS International Conference and Exhibition, Jan. 23-27, 2021, in San Diego, CA, USA.
Scientists, engineers, academics, and business leaders from academia, government and industry are invited to submit podium and poster abstracts in a wide range of cutting-edge educational tracks. Contributions from graduate students, post-doctoral associates and junior faculty are highly encouraged.
Podium Abstract Submissions Due:
Monday, September 14, 2020
Innovation Award Submission Deadline:
Monday, September 14, 2020
Tony B. Academic Travel Award Podium Submissions Due:
Monday, September 14, 2020
Tony B. Academic Travel Award Poster Submissions Due:
Monday, October 5, 2020
Podium Abstract Decisions Communicated:
Monday, October 12, 2020
Innovation AveNEW Application Deadline:
Monday, October 12, 2020
Poster Abstract Submissions Due:
Monday, October 19, 2020
(Deadline for inclusion in Student Poster Competition)
Monday, January 11, 2021
(Final Poster Abstract Submission Deadline)
Poster Abstract Decisions Communicated:
Beginning October 28, 2020
(On a monthly basis thereafter through Final Deadline.)
SLAS Ignite Award Opt-In Deadline:
Monday, November 23, 2020
New Product Award Application Deadline:
Monday, January 4, 2021
The SLAS Innovation Award is a $10,000 cash prize recognizing the extraordinary work behind one unique and special podium presentation. Click here [link to Innovation Award page] for complete details.
The Tony B. Academic Travel Awards Program is an exclusive opportunity for presenters to get additional travel funding for the SLAS International Conference and Exhibition, including airfare or mileage reimbursement, conference registration and shared accommodations. Students, graduate students, postdoctoral associates and junior faculty are encouraged to apply. Click here for complete details on the Tony B. Academic Travel Award program.
The SLAS Student Poster Award recognizes innovative research by students, graduate students, post-doctoral associates and junior faculty (less than four years in first academic appointment) who are chosen to present a poster at the SLAS International Conference and Exhibition.
The Top 3 winners will receive a cash award of $500 each. The poster award ceremony will take place on Monday, January 25 in the SLAS Booth.
The SLAS Ignite Award recognizes the best start-up or emerging company exhibiting within Innovation AveNEW, a specially designated area within the Exhibition.
Companies selected to exhibit within Innovation AveNEW, and who opt-in to compete for the SLAS Ignite Award, will be judged by an SLAS panel on a combination of key concepts, including their marketing plan, market presence and potential; funding prospects; plan for growth and the existence of a balanced company leadership, among other qualities.
Gain extra recognition for your company’s new product or service by entering the SLAS New Product Award competition. This is the perfect opportunity to showcase your product through invaluable pre-conference publicity and on-site visibility.
To simplify your submission process, make sure to have all of your materials together prior to submitting your abstract. Screen shots of each step in the abstract process will be viewing by using the 'Guidelines' section of the submission site.
To submit, the following documents are needed:
To view a sample abstract, which adheres to these guidelines, please click here.
Selected speakers must agree to the following:
All presenters must be registered as full conference participants. Limited funds may be available to assist with travel and/or hotel funding. These funds are based on availability and financial need. Contact Meghan Schofield at email@example.com for more information.
All poster presenters must be registered as full conference unless you are registered as an SLAS exhibitor.